Dated: November 6, 2007. DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE
Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Drug Enforcement Administration Drug Enforcement Administration Diversion Control, Drug Enforcement Administration. Manufacturer of Controlled Importer of Controlled Substances; [FR Doc. E7–22515 Filed 11–15–07; 8:45 am] Substances; Notice of Registration Notice of Application BILLING CODE 4410–09–P Pursuant to 21 U.S.C. 958(i), the By Notice dated June 26, 2007, and Attorney General shall, prior to issuing published in the Federal Register on a registration under this Section to a DEPARTMENT OF JUSTICE July 5, 2007, (72 FR 36729), Dade bulk manufacturer of a controlled Behring Inc., Regulatory Affairs, Quality substance in schedule I or II and prior Drug Enforcement Administration Systems, 20400 Mariani Avenue, to issuing a registration under 21 U.S.C. Cupertino, California 95014, made 952(a)(2) authorizing the importation of Manufacturer of Controlled application by renewal to the Drug such a substance, provide Substances; Notice of Registration Enforcement Administration (DEA) to manufacturers holding registrations for By Notice dated June 26, 2007, and be registered as a bulk manufacturer of the bulk manufacture of the substance published in the Federal Register on the basic classes of controlled an opportunity for a hearing. July 3, 2007, (72 FR 36481), Dade substances listed in schedule I and II: Therefore, in accordance with Title 21 Behring, Inc., 100 GBC Drive, MS514, Code of Federal Regulations (CFR), Post Office Box 6101, Attention: RA/GS, Drug Schedule 1301.34(a), this is notice that on June Newark, Delaware 19714–6101, made 22, 2007, Fisher Clinical Services Inc., application by renewal to the Drug Tetrahydrocannabinols (7370) ..... I 7554 Schantz Road, Allentown, Enforcement Administration (DEA) to Benzoylecgonine (9180) ............... II Pennsylvania 18106, made application be registered as a bulk manufacturer of Morphine (9300) ........................... II by renewal to the Drug Enforcement the basic classes of controlled Administration (DEA) to be registered as substances listed in schedule I and II: The company plans to produce the an importer of Noroxymorphone (9668), listed controlled substances in bulk to a basic class of controlled substance Drug Schedule be used in the manufacture of reagents listed in schedule II. and drug calibrator/controls for DEA The company plans to import the Tetrahydrocannabinols (7370) ..... I exempt products. listed substance for analytical research Benzoylecgonine (9180) ............... II Morphine (9300) ........................... II and clinical trials. No comments or objections have been Any bulk manufacturer who is received. DEA has considered the The company plans to produce the presently, or is applying to be, factors in 21 U.S.C. 823(a) and registered with DEA to manufacture listed controlled substances in bulk to determined that the registration of Dade be used in the manufacture of reagents such basic class of controlled substance Behring, Inc. to manufacture the listed may file comments or objections to the and drug calibrator/controls for DEA basic classes of controlled substances is exempt products. issuance of the proposed registration consistent with the public interest at and may, at the same time, file a written No comments or objections have been this time. DEA has investigated Dade received. DEA has considered the request for a hearing on such Behring, Inc. to ensure that the application pursuant to 21 CFR 1301.43 factors in 21 U.S.C. 823(a) and company’s registration is consistent determined that the registration of Dade and in such form as prescribed by 21 with the public interest. The CFR 1316.47. Behring, Inc. to manufacture the listed investigation has included inspection Any such comments or objections basic class of controlled substance is and testing of the company’s physical being sent via regular mail should be consistent with the public interest at security systems, verification of the addressed, in quintuplicate, to the Drug this time. DEA has investigated Dade company’s compliance with state and Enforcement Administration, Office of Behring, Inc. to ensure that the local laws, and a review of the Diversion Control, Federal Register company’s registration is consistent company’s background and history. Representative (ODL), Washington, DC with the public interest. The Therefore, pursuant to 21 U.S.C. 823, 20537, or any being sent via express investigation has included inspection and in accordance with 21 CFR 1301.33, mail should be sent to Drug and testing of the company’s physical the above named company is granted Enforcement Administration, Office of security systems, verification of the registration as a bulk manufacturer of Diversion Control, Federal Register company’s compliance with state and the basic classes of controlled Representative (ODL), 8701 Morrissette local laws, and a review of the substances listed. Drive, Springfield, VA 22152; and must company’s background and history. be filed no later than December 17, Therefore, pursuant to 21 U.S.C. 823, Dated: November 5, 2007. 2007. and in accordance with 21 CFR 1301.33, Joseph T. Rannazzisi, This procedure is to be conducted the above named company is granted Deputy Assistant Administrator, Office of simultaneously with, and independent registration as a bulk manufacturer of Diversion Control, Drug Enforcement of, the procedures described in 21 CFR the basic classes of controlled Administration. § 1301.34(b), (c), (d), (e) and (f). As substances listed. [FR Doc. E7–22477 Filed 11–15–07; 8:45 am] noted in a previous notice published in Dated: November 5, 2007. the Federal Register on September 23, BILLING CODE 4410–09–P mstockstill on PROD1PC66 with NOTICES
Joseph T. Rannazzisi, 1975, (40 FR 43745–46), all applicants
Deputy Assistant Administrator, Office of for registration to import a basic class of Diversion Control, Drug Enforcement any controlled substances in schedule I Administration. or II are and will continue to be required [FR Doc. E7–22470 Filed 11–15–07; 8:45 am] to demonstrate to the Deputy Assistant BILLING CODE 4410–09–P Administrator, Office of Diversion
VerDate Aug<31>2005 21:48 Nov 15, 2007 Jkt 214001 PO 00000 Frm 00105 Fmt 4703 Sfmt 4703 E:\FR\FM\16NON1.SGM 16NON1